- Home
- CHCT vs LAB Comparison
CHCT vs LAB Comparison
Compare CHCT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHCT
- LAB
- Stock Information
- Founded
- CHCT 2014
- LAB 1999
- Country
- CHCT United States
- LAB United States
- Employees
- CHCT N/A
- LAB N/A
- Industry
- CHCT Real Estate Investment Trusts
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- CHCT Real Estate
- LAB Industrials
- Exchange
- CHCT Nasdaq
- LAB Nasdaq
- Market Cap
- CHCT 425.5M
- LAB 504.2M
- IPO Year
- CHCT 2015
- LAB 2011
- Fundamental
- Price
- CHCT $14.69
- LAB $1.14
- Analyst Decision
- CHCT Buy
- LAB Hold
- Analyst Count
- CHCT 2
- LAB 1
- Target Price
- CHCT $18.00
- LAB N/A
- AVG Volume (30 Days)
- CHCT 245.3K
- LAB 1.6M
- Earning Date
- CHCT 10-28-2025
- LAB 11-04-2025
- Dividend Yield
- CHCT 12.93%
- LAB N/A
- EPS Growth
- CHCT N/A
- LAB N/A
- EPS
- CHCT N/A
- LAB N/A
- Revenue
- CHCT $119,547,000.00
- LAB $172,271,000.00
- Revenue This Year
- CHCT $6.73
- LAB N/A
- Revenue Next Year
- CHCT $6.07
- LAB N/A
- P/E Ratio
- CHCT N/A
- LAB N/A
- Revenue Growth
- CHCT 3.40
- LAB 76.33
- 52 Week Low
- CHCT $13.23
- LAB $0.92
- 52 Week High
- CHCT $20.87
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- CHCT 54.91
- LAB 39.57
- Support Level
- CHCT $14.18
- LAB $1.12
- Resistance Level
- CHCT $14.88
- LAB $1.25
- Average True Range (ATR)
- CHCT 0.40
- LAB 0.08
- MACD
- CHCT 0.10
- LAB -0.02
- Stochastic Oscillator
- CHCT 64.74
- LAB 8.91
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.